Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nyxoah SA

6.14
+0.15002.50%
Volume:68.42K
Turnover:409.24K
Market Cap:229.80M
PE:-3.28
High:6.20
Open:5.93
Low:5.81
Close:5.99
Loading ...

Conditional Issuance of Shares

GlobeNewswire
·
16 Apr

Nyxoah Expects to Meet Final FDA Requirements for Sleep Apnea Treatment Device Approval in Q2

MT Newswires Live
·
08 Apr

Nyxoah Provides Update on FDA Approvable Letter for Genio System

GlobeNewswire
·
08 Apr

Nyxoah price target lowered to $15 from $17 at H.C. Wainwright

TIPRANKS
·
26 Mar

Nyxoah announces FDA approvable letter for Genio pre-market approval application

TIPRANKS
·
26 Mar

Nyxoah Says FDA Issues Approvable Letter for Genio System

MT Newswires Live
·
26 Mar

FDA Issues Nyxoah an Approvable Letter for its Genio® System

GlobeNewswire
·
26 Mar

Nyxoah files $200M mixed securities shelf

TIPRANKS
·
21 Mar

Nyxoah SA (NYXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic US ...

GuruFocus.com
·
14 Mar

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Key Economic Reports

MT Newswires Live
·
13 Mar

Nyxoah SA reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
13 Mar

Nyxoah SA (NYXH) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
13 Mar

Nyxoah's Q4 Operating Loss Widens, Revenue Declines; Shares Up Pre-Bell

MT Newswires Live
·
13 Mar

Nyxoah Q4 Sales €1.26M Down From €1.82M YoY, Operating Loss €18.3M Up From €10.8M YoY

Benzinga
·
13 Mar

Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results

GlobeNewswire
·
13 Mar

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025

GlobeNewswire
·
11 Mar

Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

GlobeNewswire
·
04 Mar

Nyxoah announces commercial launch of Genio system in the Middle East

TIPRANKS
·
19 Feb

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East

GlobeNewswire
·
19 Feb

Hims & Hers Health (HIMS) Surges 27.7%: Is This an Indication of Further Gains?

Zacks
·
14 Feb